Elevated Pentose Cycle and Glucuronyltransferase in Daunorubicin-resistant P388 Cells

Cancer Research

Volumn 50, Issue 13, 1990, Pages 3921-3927

  Gessner, Teresa ^a   Beehler, Blake C ^a   Bartels, Christopher J ^a   Baker, Raymond M ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAUNORUBICIN; DAUNORUBICINOL; DOXORUBICIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; DRUG RESISTANCE; LEUKEMIA CELL; MOUSE; NONHUMAN; PENTOSE PHOSPHATE CYCLE; PRIORITY JOURNAL;

ANIMAL; CARBON DIOXIDE; CARMUSTINE; CELL SURVIVAL; DAUNORUBICIN; DOXORUBICIN; DRUG RESISTANCE; GLUCOSE; GLUCURONOSYLTRANSFERASE; LEUKEMIA P388; LEUKEMIA, EXPERIMENTAL; PENTOSEPHOSPHATE PATHWAY; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025289481     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Baker, R. M., and Ling, V. Membrane mutants of mammalian cells in culture. Methods Membr. Biol., 9: 333–352, 1978.
2. Biedler, J. L., and Peterson, R. H. F. Altered plasma membrane glycoconjugates of Chinese hamster cells with acquired resistance to Actinomycin D, Daunorubicin and Vincristine. In: A. C. Sartorelli, J. S. Lazo, and J. R. Bertino (eds)., Molecular Actions and Targets for Chemotherapeutic Agents, pp. 453–476. New York: Academic Press, 1981.
3. Kartner, N., Riordan, J. R., and Ling, V. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science (Wash. DC), 722: 1285–1287, 1983.
4. Giavazzi, R., Kartner, N., and Hart, I. R. Expression of cell surface P-glycoprotein by an Adriamycin-resistant murine fibrosarcoma. Cancer Chemother. Pharmacol, 13: 145–147, 1984.
5. Fairchild, C. R., Ivy, S. P., Kao-Shan, C-S., Whang-Peng, J., Rosen, N., Israel, M. A., Melera, P. W., Cowan, K. H., and Goldsmith, M. E. Isolation of amplified and overexpressed DNA sequences from Adriamycin-resistant human breast cancer cells. Cancer Res., 47: 5141–5148, 1987.
6. Inaba, M., and Sakurai, Y. Enhanced efflux of actinomycin D, vincristine, and vinblastine in Adriamycin-resistant subline of P388 leukemia. Cancer Lett., 8: 111–115, 1979.
7. Kessel, D., and Wilberding, C. Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists. Cancer Res., 45: 1687–1691, 1985.
8. Zijlstra, J. G., deVries, E. G. E., and Mulder, N. H. Multifactorial drug resistance in an Adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res., 47: 1780–1784, 1987.
9. Ramu, A., Cohen, L., and Glaubiger, D. Oxygen radical detoxification enzymes in doxorobucin-sensitive and -resistant P388 murine leukemia cells. Cancer Res., 44: 1976–1980, 1984.
10. Batist, G., Tulpule, A., Sinha, B. K., Katki, A. G., Myers, G. E., and Cowans, K. H. Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J. Biol. Chem., 261: 15544–15549, 1986.
11. Yeh, G. C., Occhipinti, S. J., Cowan, K. H., Chabner, B. A., and Myers, C. E. Adriamycin resistance in human tumor cells associated with marked alterations in the regulation of the hexose monophosphate shunt and its response to oxidant stress. Cancer Res., 47: 5994–5999, 1987.
12. Meijer, C., Mulder, N. H., Timmer-Bosscha, H., Zijlstra, J. G., and deVries, E. G. E. Role of free radicals in an Adriamycin-resistant human small cell lung cancer cell line. Cancer Res., 47: 4613–4617, 1987.
13. Inaba, M., and Johnson, R. K. Uptake and retention of Adriamycin and daunorubicin by sensitive and anthracycline-resistant sublines of P388 leukemia. Biochem. Pharmacol., 27: 2123–2130, 1978.
14. Inaba, M., Kobayashi, H., Sakurai, Y., and Johnson, R. Active efflux of daunorubicin and Adriamycin in sensitive and resistant sublines of P388 leukemia. Cancer Res., 39: 2200–2203, 1979.
15. McGown, T., Ward, T. H., and Fox, B. W. Comparative studies of the uptake of daunorubicin in sensitive and resistant P388 cell lines by flow cytometry and biochemical extraction procedures. Cancer Chemother. Pharmacol., 11: 113–116, 1983.
16. Ganapathi, R., and Grabowski, D. Enhancement of sensitivity to Adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine. Cancer Res., 43: 3696–3699, 1983.
17. Goldenberg, G. J., Wang, H., and Blair, G. W. Resistance to Adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of Adriamycin-sensitive and -resistant P388 leukemia. Cancer Res., 46: 2978–2983, 1986.
18. Capranico, G., Dasdia, T., and Zunino, F. Comparison of doxorubicin-induced DNA damage in doxorubicin-sensitive and -resistant P388 murine leukemia cells. Int. J. Cancer, 37: 227–231, 1986.
19. Clark, C. R., Chou, T. H., and Chen, B.D.-M. Alkaline stable cellular protein phosphorylation in murine leukemia P388 cell line and its Adriamycin-resistant sublines. Proc. Am. Assoc. Cancer Res., 28: 294, 1987.
20. Kessel, D., and Corbett, T. Correlations between anthracycline resistance, drug accumulation and membrane glycoprotein patterns in solid tumors of mice. Cancer Lett., 28: 187–193, 1985.
21. Deffie, A. M., Alam, T., Seneviratne, C., Beenken, S. W., Batra, J. L., Shea, T. C., Henner, W. D., and Goldenberg, G. J. Multifactorial resistance to Adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of Adriamycin-sensitive and -resistant P388 leukemia. Cancer Res., 48: 3595–3602, 1988.
22. Kramer, R. A., Zakher, J., and Kim, G. Role of the glutathione redox cycle in acquired and de novo multidrug resistance. Science (Wash. DC), 241: 694–697, 1988.
23. Mungikar, A., Chitnis, M., and Gothoskar, B. Mixed-function oxidase enzymes in Adriamycin-sensitive and -resistant sublines of P-388 leukemia. Chem.-Biol. Interact., 35: 119–124, 1981.
24. Londos-Gagliardi, D., Baurain, R., Robert, J., and Aubel-Sadron, G. Metabolism of daunorubicin in sensitive and resistant Ehrlich ascites tumor cells: determination by high pressure liquid chromotography. Cancer Chemother. Pharmacol., 9: 45–48, 1982.
25. Kartner, N., Shales, M., Riordan, J. R., and Ling, V. Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein. Cancer Res., 43: 4413–4419, 1983.
26. Ahmed, N. K. Biochemical basis for daunorubicin resistance and its reversal in ML1 human leukemic cell lines. Proc. Am. Assoc. Cancer Res., 27: 390, 1986.
27. Vasanthakumar, G., and Ahmed, N. K. Contribution of drug transport and reductases to daunorubicin resistance in human myelocytic cells. Cancer Chemother. Pharmacol., 18: 105–110, 1986.
28. Peterson, R. H. F., Meyers, M. B., Spengler, B. A., and Biedler, J. L. Alteration of plasma membrane glycopeptides and gangliosides of Chinese hamster cells accompanying developing of resistance to daunorubicin and vincristine. Cancer Res., 43: 222–228, 1983.
29. Gessner, T., Bartels, C. J., and Vaughan, L. A. Metabolic resistance to daunorubicin in P388 drug-resistant cell line. Blood, 66: 199a, 1985.
30. Gessner, T., and Vaughan, L. A. Increased pentose cycle activity in P388DR resistant cells. Pharmacologist, 20: 220, 1987.
31. Gessner, T., Vaughan, L. A. and Beehler, B. C. Increased defense against oxidative stress in daunorubicin (DAU) resistant P388 leukemia cells. J. FASEB, 3: A740, 1989.
32. Bolanowska, W., Gessner, T., and Preisler, H. A simplified method for determination of daunorubicin, Adriamycin, and their chief fluorescent metabolites in human plasma by high-pressure liquid chromatography. Cancer Chemother. Pharmacol., 10: 187–191, 1983.
33. Bansal, S. K., and Gessner, T. A unified method for the assay of uridine diphosphoglucuronyltransferase activities towards various aglycones using uridine diphospho[U-I4C]glucuronic acid. Anal. Biochem., 109: 321–329, 1980.
34. Varnes, M. E., Tuttle, S. W., and Biaglow, J. E. Nitroheterocycle metabolism in mammalian cells: stimulation of the hexose monophosphate shunt. Biochem. Pharmacol. 33: 1671–1677, 1984.
35. Lee, C-Y. Glucose-6-phosphate dehydrogenase from mouse. Methods Enzymol. E9: 252–257, 1982.
36. Pearse, B. M. F., and Rosemeyer, M. A. 6-Phosphogluconate dehydrogenase from human erythrocytes. Methods Enzymol., 41: 220–226, 1975.
37. Plaut, G. W. E., and Sung, S-C. Diphosphopyridine nucleotide isocitric dehydrogenase from animal tissues. Methods Enzymol., 1: 710–713, 1955.
38. Li, H. C., Porter, N., and Gessner, T. Enzymatic properties of human glucuronyltransferase and a sensitive method for its assay in a stable B lymphocyte cell line. Enzyme (Basel), 28: 54–65, 1982.
39. Li, H. C., Porter, N., Holmes, G., and Gessner, T. Substrate specificity of human UDP-glucuronyltransferase in cultured lymphocytes. Xenobiotica, 77: 647–654, 1981.
40. Yin, Z., Sato, K., Tsuda, H., and Ito, N. Changes in activities of uridine diphosphate-glucuronyltransferases during chemical hepatocarcinogenesis. Gann, 73: 239–248, 1982.
41. Bock, K. W., Clausbruch, C. V., Kaufmann, R., Lilienblum, W., Oesch, F., Pfeil, H., and Piatt, K. L. Functional heterogeneity of UDP-glucuronyltransferase in rat tissues. Biochem. Pharmacol., 29: 495–500, 1980.
42. Merrick, B. A., and Selkirk, J. K. H.P.L.C. of benzo(a)pyrene glucuronide, sulfate and glutathione conjugates and water-soluble metabolites from hamster embryo fibroblasts. Carcinogenesis (Lond.), 6: 1303–1307, 1985.
43. Gessner, T., and Byczkowski, J. A simplified method for determination of radioactive metabolites of benzo(a)pyrene using HPLC with radioactive flow detection. Prog. HPLC, 3: 149–165, 1988.
44. Skipper, H. E. The effects of chemotherapy on the kinetics of leukemic cell behaviour. Cancer Res., 25: 1544–1550, 1965.
45. Reed, D. L. Regulation of reductive processes by glutathione. Biochem. Pharmacol., 35: 7–13, 1986.
46. Byczkowski, J. Z., and Gessner, T. Interaction between vitamin K3 and benzo(la)pyrene metabolism in uninduced microsomes. Int. J. Biochem., 19: 1173–1179, 1987.
47. Johnson, R. K., Chitnis, M. P., Embrey, W. M., and Gregory, E. B. In vivo characteristics of resistance and cross-resistance of an Adriamycin-resistant subline of P388 leukemia. Cancer Treat. Rep., 62: 1535–1547, 1978.
48. Jones, C. A., Moore, B. P., Cohen, G. M., Fry, J. R., and Bridges, J. W. Studies on the metabolism and excretion of benzo(a)pyrene in isolated adult rat hepatocytes. Biochem. Pharmacol., 22: 693–701, 1978.
49. Cowan, K. H., Batist, G., Tulpule, A., Sinha, B. K., and Myers, C. E. Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats. Proc. Natl. Acad. Sci. USA, 83: 9328–9332, 1986.
50. Sinha, B. K., Mimnaugh, E. G., Rajagopalan, S., and Myers, C. E. Adriamycin activation and oxygen free radical formation in human breast tumor cells: protective role of glutathione peroxidase in Adriamycin resistance. Cancer Res., 49: 3844–3848, 1989.
51. Eggleston, L. V., and Krebs, H. A. Regulation of the pentose phosphate cycle. J. Biochem., 138: 425–435, 1974.
52. Forman, H. J., and Fisher, A. B. Antioxidant enzymes of rat granular pneumocytes: constitutive levels and effect of hyperoxia. Lab. Invest., 45: 1–6, 1981.